These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6085104)

  • 1. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
    Looker DN
    J Hosp Infect; 1984 Dec; 5(4):459. PubMed ID: 6085104
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
    Pollock AV; Evans M
    J Hosp Infect; 1984 Sep; 5(3):340-1. PubMed ID: 6208258
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
    Donnelly JP; Starke ID; Galton DA; Catovsky D; Goldman JM; Darrell JH
    J Hosp Infect; 1984 Mar; 5(1):83-91. PubMed ID: 6202753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia.
    Rozenberg-Arska M; Dekker AW; Branger J; Verhoef J
    J Antimicrob Chemother; 1991 Mar; 27(3):369-76. PubMed ID: 2037541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial.
    Benhamou E; Hartmann O; Noguès C; Maraninchi D; Valteau D; Lemerle J
    Bone Marrow Transplant; 1991 Feb; 7(2):127-31. PubMed ID: 2049556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
    Walsh TJ; Rubin M; Hathorn J; Gress J; Thaler M; Skelton J; McKnight J; Browne M; Marshall D; Cotton D
    Arch Intern Med; 1991 Apr; 151(4):765-70. PubMed ID: 2012462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.
    Hann IM; Prentice HG; Corringham R; Blacklock HA; Keaney M; Shannon M; Noone P; Gascoigne E; Fox J; Boesen E; Szawatkowski M; Hoffbrand AV
    Lancet; 1982 Apr; 1(8276):826-9. PubMed ID: 6122057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and treatment of fungal infections in neutropenic patients.
    von Paleske A; Müllerleile U; Gressler V; Garbrecht M; Hossfeld DK
    Haematol Blood Transfus; 1987; 30():545-6. PubMed ID: 3476385
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia.
    Rodu B; Carpenter JT; Jones MR
    Cancer; 1988 Nov; 62(9):2042-6. PubMed ID: 3167816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Muñoz P; Bouza E
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
    Grasela TH; Goodwin SD; Pasko MT; Walawander CA; Raebel MA
    Ann Pharmacother; 1994 Feb; 28(2):252-60. PubMed ID: 8173147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy of systemic fungal infections, Part I.
    Gross M
    N C Med J; 1984 Aug; 45(8):515-7. PubMed ID: 6089006
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ketoconazole and antifungal prevention in leukemia. Pharmacokinetic study].
    Mazzoni A; Fiorentini C; Luglio G
    G Ital Chemioter; 1984; 31(1-2):163-8. PubMed ID: 6088339
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 15. Amphotericin B. Still the 'gold standard' for antifungal therapy.
    Sarosi GA
    Postgrad Med; 1990 Jul; 88(1):151-2, 155-61, 165-6. PubMed ID: 2195479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
    Caselli D; Aricò M; Michelone G; Cavanna C; Nespoli L; Burgio GR
    Microbiologica; 1990 Oct; 13(4):347-51. PubMed ID: 1965007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Itraconazole in neutropenic patients.
    van't Wout JW
    Chemotherapy; 1992; 38 Suppl 1():23-6. PubMed ID: 1319311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.
    Cauwenbergh G
    Drugs Exp Clin Res; 1986; 12(5):419-27. PubMed ID: 3522162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective systemic antifungal agents.
    Lefrock JL; Smith BR
    Am Fam Physician; 1984 Dec; 30(6):162-7. PubMed ID: 6095631
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of oral high-dose amphotericin B in patients with acute leukemia: detection of fungi and prophylaxis for fungal infection].
    Motomura S; Noguchi T; Kanamori H; Murata T; Harano H; Takahashi K; Matsuzaki M; Miyashita H; Ogawa K; Ito A
    Rinsho Ketsueki; 1987 Nov; 28(11):1956-62. PubMed ID: 3446867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.